- Home
- RVMD vs CORT Comparison
RVMD vs CORT Comparison
Compare RVMD & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | CORT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 7.6B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RVMD | CORT |
|---|---|---|
| Price | $77.65 | $83.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 5 |
| Target Price | $77.11 | ★ $139.00 |
| AVG Volume (30 Days) | ★ 2.3M | 637.8K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $741,172,000.00 |
| Revenue This Year | N/A | $23.79 |
| Revenue Next Year | $714.50 | $40.97 |
| P/E Ratio | ★ N/A | $95.78 |
| Revenue Growth | N/A | ★ 17.92 |
| 52 Week Low | $29.17 | $49.00 |
| 52 Week High | $79.07 | $117.33 |
Technical Indicators
Market Signals| Indicator | RVMD | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 79.18 | 66.15 |
| Support Level | $69.50 | $77.55 |
| Resistance Level | $78.17 | $81.41 |
| Average True Range (ATR) | 2.78 | 2.72 |
| MACD | 0.17 | 0.77 |
| Stochastic Oscillator | 90.88 | 95.04 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.